Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors

Nilda Gonzalez-Roibon, Betina Katz, Alcides Chaux, Rajni Sharma, Enrico Munari, Sheila F. Faraj, Peter B. Illei, Michael Torbenson, George J. Netto

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

SALL4 is a transcription factor that serves as a marker of yolk sac tumor. Yolk sac tumor and hepatocellular carcinoma share histologic, serologic, and immunohistochemical features. Previous studies have shown lack of SALL4 expression in hepatocellular carcinoma, suggesting utility in this differential diagnosis. Sixty-nine samples of hepatocellular carcinoma were retrieved from surgical pathology archives and used to construct 9 tissue microarrays. A germ cell tumor tissue microarray containing 10 yolk sac tumors was used for comparison. Extent, intensity, and pattern of nuclear SALL4 expression were assessed in each spot. Mean percentage of expression was calculated for each tumor and used during analysis. Optimal discriminatory extent of expression cutoff was determined by receiver operating characteristic curve analysis. Other potential discriminatory markers including Hep Par1 were also evaluated. Forty-six percent (32/69) of hepatocellular carcinoma and all yolk sac tumors revealed at least focal expression of SALL4. A unique punctuate/clumped pattern of nuclear staining was present in 94% (30/32) of hepatocellular carcinoma, whereas all yolk sac tumors displayed a diffuse finely granular nuclear staining pattern. A 25% extent of SALL4 expression cutoff was found to be optimal for the distinction of yolk sac tumor from hepatocellular carcinoma yielding a sensitivity of 100%, specificity of 92.8%, and a positive predictive value of 66.6% for yolk sac tumor diagnosis. The addition of Hep Par1 increased the specificity (99%) and positive predictive value (90%). This is the first report of SALL4 expression in hepatocellular carcinoma. Our finding should be taken into consideration in the differential diagnosis of hepatocellular carcinoma and yolk sac tumor. The unique punctuate/clumped pattern seen in hepatocellular carcinoma cases could be of further discriminatory value.

Original languageEnglish (US)
Pages (from-to)1293-1299
Number of pages7
JournalHuman Pathology
Volume44
Issue number7
DOIs
StatePublished - Jul 1 2013
Externally publishedYes

Fingerprint

Endodermal Sinus Tumor
Hepatocellular Carcinoma
Differential Diagnosis
Staining and Labeling
Surgical Pathology
Germ Cell and Embryonal Neoplasms
ROC Curve
Transcription Factors
Sensitivity and Specificity

Keywords

  • Hepatocellular carcinoma
  • SALL4
  • Yolk sac tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. / Gonzalez-Roibon, Nilda; Katz, Betina; Chaux, Alcides; Sharma, Rajni; Munari, Enrico; Faraj, Sheila F.; Illei, Peter B.; Torbenson, Michael; Netto, George J.

In: Human Pathology, Vol. 44, No. 7, 01.07.2013, p. 1293-1299.

Research output: Contribution to journalArticle

Gonzalez-Roibon, Nilda ; Katz, Betina ; Chaux, Alcides ; Sharma, Rajni ; Munari, Enrico ; Faraj, Sheila F. ; Illei, Peter B. ; Torbenson, Michael ; Netto, George J. / Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. In: Human Pathology. 2013 ; Vol. 44, No. 7. pp. 1293-1299.
@article{f28f92db188e45f493e2bd5cba146330,
title = "Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors",
abstract = "SALL4 is a transcription factor that serves as a marker of yolk sac tumor. Yolk sac tumor and hepatocellular carcinoma share histologic, serologic, and immunohistochemical features. Previous studies have shown lack of SALL4 expression in hepatocellular carcinoma, suggesting utility in this differential diagnosis. Sixty-nine samples of hepatocellular carcinoma were retrieved from surgical pathology archives and used to construct 9 tissue microarrays. A germ cell tumor tissue microarray containing 10 yolk sac tumors was used for comparison. Extent, intensity, and pattern of nuclear SALL4 expression were assessed in each spot. Mean percentage of expression was calculated for each tumor and used during analysis. Optimal discriminatory extent of expression cutoff was determined by receiver operating characteristic curve analysis. Other potential discriminatory markers including Hep Par1 were also evaluated. Forty-six percent (32/69) of hepatocellular carcinoma and all yolk sac tumors revealed at least focal expression of SALL4. A unique punctuate/clumped pattern of nuclear staining was present in 94{\%} (30/32) of hepatocellular carcinoma, whereas all yolk sac tumors displayed a diffuse finely granular nuclear staining pattern. A 25{\%} extent of SALL4 expression cutoff was found to be optimal for the distinction of yolk sac tumor from hepatocellular carcinoma yielding a sensitivity of 100{\%}, specificity of 92.8{\%}, and a positive predictive value of 66.6{\%} for yolk sac tumor diagnosis. The addition of Hep Par1 increased the specificity (99{\%}) and positive predictive value (90{\%}). This is the first report of SALL4 expression in hepatocellular carcinoma. Our finding should be taken into consideration in the differential diagnosis of hepatocellular carcinoma and yolk sac tumor. The unique punctuate/clumped pattern seen in hepatocellular carcinoma cases could be of further discriminatory value.",
keywords = "Hepatocellular carcinoma, SALL4, Yolk sac tumor",
author = "Nilda Gonzalez-Roibon and Betina Katz and Alcides Chaux and Rajni Sharma and Enrico Munari and Faraj, {Sheila F.} and Illei, {Peter B.} and Michael Torbenson and Netto, {George J.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.humpath.2012.10.017",
language = "English (US)",
volume = "44",
pages = "1293--1299",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors

AU - Gonzalez-Roibon, Nilda

AU - Katz, Betina

AU - Chaux, Alcides

AU - Sharma, Rajni

AU - Munari, Enrico

AU - Faraj, Sheila F.

AU - Illei, Peter B.

AU - Torbenson, Michael

AU - Netto, George J.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - SALL4 is a transcription factor that serves as a marker of yolk sac tumor. Yolk sac tumor and hepatocellular carcinoma share histologic, serologic, and immunohistochemical features. Previous studies have shown lack of SALL4 expression in hepatocellular carcinoma, suggesting utility in this differential diagnosis. Sixty-nine samples of hepatocellular carcinoma were retrieved from surgical pathology archives and used to construct 9 tissue microarrays. A germ cell tumor tissue microarray containing 10 yolk sac tumors was used for comparison. Extent, intensity, and pattern of nuclear SALL4 expression were assessed in each spot. Mean percentage of expression was calculated for each tumor and used during analysis. Optimal discriminatory extent of expression cutoff was determined by receiver operating characteristic curve analysis. Other potential discriminatory markers including Hep Par1 were also evaluated. Forty-six percent (32/69) of hepatocellular carcinoma and all yolk sac tumors revealed at least focal expression of SALL4. A unique punctuate/clumped pattern of nuclear staining was present in 94% (30/32) of hepatocellular carcinoma, whereas all yolk sac tumors displayed a diffuse finely granular nuclear staining pattern. A 25% extent of SALL4 expression cutoff was found to be optimal for the distinction of yolk sac tumor from hepatocellular carcinoma yielding a sensitivity of 100%, specificity of 92.8%, and a positive predictive value of 66.6% for yolk sac tumor diagnosis. The addition of Hep Par1 increased the specificity (99%) and positive predictive value (90%). This is the first report of SALL4 expression in hepatocellular carcinoma. Our finding should be taken into consideration in the differential diagnosis of hepatocellular carcinoma and yolk sac tumor. The unique punctuate/clumped pattern seen in hepatocellular carcinoma cases could be of further discriminatory value.

AB - SALL4 is a transcription factor that serves as a marker of yolk sac tumor. Yolk sac tumor and hepatocellular carcinoma share histologic, serologic, and immunohistochemical features. Previous studies have shown lack of SALL4 expression in hepatocellular carcinoma, suggesting utility in this differential diagnosis. Sixty-nine samples of hepatocellular carcinoma were retrieved from surgical pathology archives and used to construct 9 tissue microarrays. A germ cell tumor tissue microarray containing 10 yolk sac tumors was used for comparison. Extent, intensity, and pattern of nuclear SALL4 expression were assessed in each spot. Mean percentage of expression was calculated for each tumor and used during analysis. Optimal discriminatory extent of expression cutoff was determined by receiver operating characteristic curve analysis. Other potential discriminatory markers including Hep Par1 were also evaluated. Forty-six percent (32/69) of hepatocellular carcinoma and all yolk sac tumors revealed at least focal expression of SALL4. A unique punctuate/clumped pattern of nuclear staining was present in 94% (30/32) of hepatocellular carcinoma, whereas all yolk sac tumors displayed a diffuse finely granular nuclear staining pattern. A 25% extent of SALL4 expression cutoff was found to be optimal for the distinction of yolk sac tumor from hepatocellular carcinoma yielding a sensitivity of 100%, specificity of 92.8%, and a positive predictive value of 66.6% for yolk sac tumor diagnosis. The addition of Hep Par1 increased the specificity (99%) and positive predictive value (90%). This is the first report of SALL4 expression in hepatocellular carcinoma. Our finding should be taken into consideration in the differential diagnosis of hepatocellular carcinoma and yolk sac tumor. The unique punctuate/clumped pattern seen in hepatocellular carcinoma cases could be of further discriminatory value.

KW - Hepatocellular carcinoma

KW - SALL4

KW - Yolk sac tumor

UR - http://www.scopus.com/inward/record.url?scp=84879249821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879249821&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2012.10.017

DO - 10.1016/j.humpath.2012.10.017

M3 - Article

C2 - 23347651

AN - SCOPUS:84879249821

VL - 44

SP - 1293

EP - 1299

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 7

ER -